Rivera CL

Idioma: Español
Referencias bibliográficas: 57
Paginas: 146-152
Archivo PDF: 89.44 Kb.

RESUMEN

La apnea obstructiva del sueño es el trastorno respiratorio más frecuente en hombres que en mujeres. La hipoxia crónica intermitente resulta de esta patología, y la activación simpática con microdespertares, que tienen como finalidad restablecer el tono muscular de la vía aérea superior para restablecer la respiración, ocasionan alteraciones en la actividad cardiaca y variaciones fisiológicas importantes en la secreción endocrina de otros sistemas circadianos. Es fundamental la investigación de los factores de riesgo que permita incidir en la prevención no sólo de los factores de riesgo tradicionales como la hipertensión arterial sistémica, diabetes mellitus, hiperlipidemias, obesidad, tabaquismo, valvulopatía o cardiomiopatías, sino también de los nuevos factores de riesgo como el aumento de la homocisteína plasmática o procesos inflamatorios, la gingivitis crónica y, muy particularmente, los trastornos respiratorios del sueño como la apnea obstructiva del sueño, que frecuentemente son poco diagnosticados.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Agnoli A, Manfredi M, Mossuto L, et al. Rapport entre les rythmes héméronyctaux de la thension artérielle et sa pathogenie de l’insuffiÇance vasculaire cérébrale. Rev Neurol 1975; 131: 597-606.

2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disorders breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.

3. Murria CJL, López AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-76.

4. Palomäki H, Partinen M, Juvela S, Kaste M. Snoring as a risk factor for sleep-related brain infarction. Stroke 1989; 20: 1311-5.

5. Guilleminualt C, Eldrige FL, Dement WC. Insomnia with sleep apnea, a new syndrome. Science 1973; 181: 856-8.

6. Guilleminault C, Tikian A, Dement WC. The sleep apnea syndromes. Ann Rev Med 1976; 27: 465-84.

7. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea experience in 385 male patients. Chest 1988; 94: 9-14.

8. Bassetti C, Aldrich M. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1998; 22: 217-23.

9. Naëgelé B, Valérie T, Pépin JL, et al. Deficits of cognoscitive executive functions in patients with sleeps apnea syndrome. Sleep 1995; 18: 43.

10. Beran AS, Richert AC. Obstructive sleep apnea and depression. CNS Spectr 2003; 8: 120-34.

11. Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987; 10: 254.

12. Stoohs R, Guillemineault C, Itoi A, et al. Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesity. Sleep 1994; 17: 619.

13. McArdle N, Devereux G, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-14.

14. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Study. Am J Respir Crit Care Med 2001; 163: 19-25.

15. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.

16. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized parallel trial. Lancet 2002; 359: 204-10.

17. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.

18. Neau JP, Paquereau J, Meurice JC, et al. Auditory event-related potentials before and after treatment with nasal continuous positive airway pressure in sleep apnea syndrome. Eur J Neurology 1996; 3: 29-35.

19. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. Chest 1995; 96: 1897-904.

20. Kraiezi H, Hedner J, Peker Y, Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000; 89: 493-8.

21. Prabhakar NR. Sleep apneas: an oxidative stress? Am J Respir Crit Care Med 2002; 165: 859-60.

22. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-9.

23. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polimorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-70.

24. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-71.

25. Rose R. Atheroesclerosis-ann inflammatory disease. N Engl J Med 1999; 340: 115-26.

26. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999; 107: 85-97.

27. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999; 26: 74-84.

28. Vgontzas AN, Bixler EO, Papanivolauo D, et al. Plasma concentration of tumor necrosis factor alpha (TNF), interleukin-6 (IL-6), and leptin are elevated in sleep apnea independent of obesity. Sleep 1999; 22: 33.

29. Nakamura T, et al. Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome. Sleep 2001; 24: 545-53.

30. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 2000; 279: 234-7.

31. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Care Med 2002; 165: 677-82.

32. Ip MS, Lam B, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-6.

33. Ozturk L, Unal M, Tamer L, Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003; 129: 538-40.

34. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-9.

35. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4.

36. Yokoe T, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-34.

37. Malone S, Liu PP, Holloway R, Rutherford R, et al. Obstructive sleep apnea in patients with idiopatic cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338: 1480-4.

38. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-41.

39. Lanfranchi PA, Somers VK, Braghiroli A, et al. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 2003; 107: 727-32.

40. Javaheri S, Parker TJ, Living JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-9.

41. Yamashita T, Murakawa Y, Sezaki K, et al. Circadian variation of paroxysmal atrial fibrillation. Circulation 1997; 96: 1537-41.

42. Mooe T, Gullsby S, Rabben T, et al. Sleep-disordered breathing : a novel predictor of atrial fibrillation after coronary bypass surgery. Coron Artery Dis 1996; 7: 475-8.

43. Kanagala R, Murali N, Friedman P, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003 (in press).

44. Schmidt-Nowara WW, Coultas DB, Wiggins C, et al. Snoring in a Hispanic-American population. Risk factors and association with hypertension and other morbidity. Arch Intern Med 1990; 150: 597-601.

45. D’Alessandro R, Magelli C, Gaberini G, et al. Snoring every night as a risk factor for myocardial infarction: a case control study. Br Med J 1990; 300: 1557-8.

46. Hung J, Whiford EG, Parsons RW, Hillman DR. Association of sleep apnea with myocardial infarction in men. Lancet 1990; 336: 261-4.

47. Olson LG, et al. A community study of snoring and sleep-disordered breathing: health outcomes. Am J Respir Crit Care Med 1995; 152: 717-21.

48. Jennum P, et al. Risk of ischemic heart disease in self-reported snorers: a prospective study of 2937 men aged 54 to 74 years. The Copenhagen male-study. Chest 1995; 108: 138-43.

49. Lievers KJ, Kluiijtmans LA, Blom HJ. Genetics of hiperhomocysteinaemia in cardiovascular disease. Ann Clinn Biochem 2003; 40: 46-59.

50. Lavie L. Plasma homocysteine levels in obstructive apnea: association with cardiovascular morbidity. Chest 2001; 120: 900-8.

51. Spengos K, Tsivgoulis G, Manios E, et al. Stroke etiology is associated with symptom onset during sleep. Sleep 2005; 28: 233-8.

52. Rivera L. La apnea de sueño es un factor de riesgo para la enfermedad vascular cerebral. Revista Hondureña de Neurociencias 2001; 5: 41-2.

53. Iranzo A, Santamaría J, Berenguer J, et al. Prevalence and clinical importance of sleep apnea in the first night alter cerebral infarction. Neurology 2002; 58: 911-6.

54. Hermann DM, Bassetti CL. Sleep-disordered breathing and stroke. Curr Opin Neurol 2003; 16: 87-90.

55. Shahar C, Taddei T, Paladín B, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respire Crit Care Med 2001; 163: 19-25.

56. Wessendorf TE, Dahm C, Teschler H. Prevalence and clinical importance of sleep apnea in the first night alter cerebral infarction. Neurology 2003; 60: 1053.

57. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000; 161: 375-380.